Maria Ferrillo (M Ferrillo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 7

Top Topics

Respiratory Failure

Silver Nanoparticles

Hidradenitis Suppurativa

Top Venues

Dermatologic therapy

Clinical and experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Claudio Marasca, Ruggiero Angelo, G Fontanella, Maria Ferrillo, G Fabbrocini, Alessia Villani
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic. Clinical and experimental dermatology 45 (6) (2020)
Matteo Megna, Gabriella Fabbrocini, Maria Ferrillo, Eleonora Cinelli
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two cases. Dermatologic therapy 33 (6) (2020)
Cataldo Patruno, Maria Ferrillo, Gabriella Fabbrocini, Maddalena Napolitano
A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab. Dermatologic therapy 34 (1) (2020)
Matteo Megna, Gabriella Fabbrocini, Claudia Costa, Maria Ferrillo
A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar. Dermatologic therapy 33 (3) (2020)
Maria Ferrillo, Cataldo Patruno, Alessia Villani, M Scalvenzi, Gabriella Fabbrocini, M D'Andrea, Maddalena Napolitano
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (11) (2020)
Matteo Megna, Maria Ferrillo, Ruggiero Angelo, Eleonora Cinelli, Lucia Gallo, Gabriella Fabbrocini
QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study. International journal of dermatology 60 (3) (2020)
Matteo Megna, A Ruggiero, Maria Ferrillo, G Fabbrocini
QuantiFERON-TB Gold conversion is not uncommon in patients with psoriasis undergoing anti-tumour necrosis factor-α therapy. The British journal of dermatology 183 (5) (2020)